Improve breast cancer hormone test practices in Tanzania
Part of Cancer, Skin clinical trials.
This study evaluates how to improve testing of hormone receptors (which helps guide breast cancer treatment) in Tanzania. It uses interviews or focus groups with breast cancer survivors, advocates, and healthcare workers, plus reviews of existing medical records.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You live in Tanzania (citizen or permanent resident)
- You can take part as a breast cancer survivor, patient advocate, or key healthcare worker involved in breast cancer care
- If you’re a healthcare worker: you’ve worked at a partner hospital/lab for over 12 months and help deliver care
- You can consent and you speak English and/or Swahili
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests tools to help people talk with employers and medical staff about breast cancer treatment while working. It aims to improve how treatment and job needs are discussed so patients can get support.
This study uses interviews and surveys to learn about stigma related to breast and cervical cancer in Rwanda. It aims to help improve care and support for patients, caregivers, and healthcare workers.
This pilot study tests a new way to screen for breast cancer in people who have taken hormone therapy (like estrogen, progesterone, or testosterone). It aims to include both men and women between 40 and 75, and younger people (30-39) with a family history of breast cancer.
This study aims to bring breast ultrasound directly to district hospitals in Rwanda, so more women can be screened for breast cancer close to home — without having to travel long distances. It will test a new way of delivering ultrasound that is easier for patients and staff.
This study tests whether text message reminders help women with early-stage, hormone-sensitive breast cancer remember to take their daily cancer-prevention medication. The goal is to see if reminders improve how consistently women take their pills, which can help prevent cancer from coming back.
This trial supports Latina women who have higher breast cancer risk and face added barriers (like cost, transportation, safety, or isolation) to get recommended breast screening and genetic risk information. It aims to help you understand your risk and access care when it’s due.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.